FAU expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.396400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.154000E-01
Normal-vs-Stage2
4.777600E-01
Normal-vs-Stage3
4.392000E-01
Normal-vs-Stage4
7.645600E-01
Stage1-vs-Stage2
3.586200E-01
Stage1-vs-Stage3
8.317000E-01
Stage1-vs-Stage4
4.267400E-01
Stage2-vs-Stage3
2.927400E-01
Stage2-vs-Stage4
8.300200E-01
Stage3-vs-Stage4
3.842200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.553800E-01
Normal-vs-AfricanAmerican
6.477200E-01
Normal-vs-Asian
6.848400E-01
Caucasian-vs-AfricanAmerican
4.559000E-01
Caucasian-vs-Asian
7.350200E-01
AfricanAmerican-vs-Asian
5.198600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.450000E-01
Normal-vs-Female
4.594000E-01
Male-vs-Female
9.333000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.617600E-01
Normal-vs-Age(41-60Yrs)
7.096000E-01
Normal-vs-Age(61-80Yrs)
4.394400E-01
Normal-vs-Age(81-100Yrs)
9.071800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.153200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.925010E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.540000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.097200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.440400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.249500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.650400E-01
Normal-vs-Daily Drinker
9.533000E-01
Normal-vs-Weekly Drinker
6.078000E-01
Normal-vs-Occasional Drinker
7.890400E-01
Normal-vs-Social Drinker
4.253000E-01
Non Drinker-vs-Daily Drinker
1.248570E-01
Non Drinker-vs-Weekly Drinker
6.137200E-01
Non Drinker-vs-Occasional Drinker
5.057800E-01
Non Drinker-vs-Social Drinker
9.181600E-01
Daily Drinker-vs-Weekly Drinker
3.726600E-01
Daily Drinker-vs-Occasional Drinker
3.517600E-01
Daily Drinker-vs-Social Drinker
1.380170E-01
Weekly Drinker-vs-Occasional Drinker
9.266200E-01
Weekly Drinker-vs-Social Drinker
5.439400E-01
Occasional Drinker-vs-Social Drinker
4.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.363600E-01
Normal-vs-Grade 2
5.313600E-01
Normal-vs-Grade 3
6.732800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.438200E-01
Grade 1-vs-Grade 3
7.872400E-01
Grade 1-vs-Grade 4
8.363600E-01
Grade 2-vs-Grade 3
4.268200E-01
Grade 2-vs-Grade 4
5.313600E-01
Grade 3-vs-Grade 4
6.732800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.271000E-01
Normal-vs-NonDiabetic
7.589400E-01
Diabetic-vs-NonDiabetic
9.371400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.834600E-01
Normal-vs-NoPancreatitis
4.617600E-01
Pancreatitis-vs-NoPancreatitis
1.624430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.088400E-01
Normal-vs-N1
7.097200E-01
N0-vs-N1
4.645400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.319400E-01
Normal-vs-TP53-NonMutant
2.989200E-01
TP53-Mutant-vs-TP53-NonMutant
5.015000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
